课题基金 / 基金详情

项目摘要

项目成果

RUI-MING XU的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Epigenetic control of gene expression plays important roles in eukaryotic biology. Examples of epigenetic regulation include control of Hox gene expression during development and in differentiated cells, dosage compensation and aging. Many cancers are associated with altered epigenetic regulation, which involves the assembly of higher order chromatin structures. This proposal focuses on studying the molecular mechanisms by which higher order chromatin structures are established and maintained. We use X-ray crystallography as our main tool to study mechanisms by which epigenetic regulators are recruited to the silent genomic loci, structures and functions of histone modification enzymes, and the recognition of histone codes. We will study in parallel the genetically well-characterized mating-type silencing in S. cerevisiae and chromatin-associated proteins in humans. The study should provide mechanistic understanding of heterochromatin assembly in yeast, as well as providing important insights into mechanisms of epigenetic regulation of gene expression in humans. The atomic-resolution structures may also be used to aid the development of therapeutic agents against cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
STRUCTURE STUDIES OF TRANSCRIPTIONAL SILENCING
  • 批准号:
    7106829
  • 项目类别:
  • 资助金额:
    $8.59万
  • 财政年份:
    2001
  • 负责人:
    RUI-MING XU
  • 依托单位:
STRUCTURE STUDIES OF TRANSCRIPTIONAL SILENCING
  • 批准号:
    6526079
  • 项目类别:
  • 资助金额:
    $25.23万
  • 财政年份:
    2001
  • 负责人:
    RUI-MING XU
  • 依托单位:
STRUCTURE STUDIES OF TRANSCRIPTIONAL SILENCING
  • 批准号:
    6797658
  • 项目类别:
  • 资助金额:
    $6.5万
  • 财政年份:
    2001
  • 负责人:
    RUI-MING XU
  • 依托单位:
Structural Studies of Transcriptional Silencing
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: